Brief: Nanorepro starts cooperation with Glenmark in South Africa
25/05/2016 07:30
May 25 (Reuters) - Nanorepro AG NN6G.DE :
* Starts cooperation with a multinational pharmaceutical
company Glenmark in South Africa
* Cooperation starts with eight OTC tests and two tests for
the medical use
* After a successful pilot project option for exclusive
distribution agreement
Source text for Eikon: ID:nEQ7my6Wfa
Further company coverage: NN6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on NanoRepro AG
See all newsBrief: NanoRepro Enters Market For Diabetes Diagnostics
Brief: NanoRepro FY Profit After Taxes At EUR 29.7 Mln
Brief: Nanorepro Announces Talks With Viromed Group On Integration Of Individual Business Units Terminated For The Time Being
Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
Brief: NanoRepro - Change In Forecast 2021 And Outlook 2022 With Dividend